-
Article
New antitumor leads from a peptidomimetic library
A parallel combinatorial library of over 1600 compounds has been designed and synthesized for the development of new potential peptidomimetic protein tyrosine kinase (PTK) inhibitor leads. These peptidomimetic...
-
Article
New antitumor leads from a peptidomimetic library
A parallel combinatorial library of over 1600 compounds has been designed and synthesized for the development of new potential peptidomimetic protein tyrosine kinase (PTK) inhibitor leads. These peptidomimetic...
-
Chapter
Further Studies of the Signaling Mechanisms of the Antitumor Somatostatin Analogue TT-232
The somatostatin structural analogue TT-232 is a heptapeptide of a cyclopenta-ring structure: D-Phe-Cys-Tyr-D-Thr-Lys-Cys-Thr-NH2 that was shown to have strong antiproliferative and apoptotic effects on tumor cel...
-
Chapter
New Antiproliferative Agents from a Peptidomimetic Library
It is known that chiral ATP analogue quinazolines show selective Epidermal Growth Factor Receptor Tyrosine Kinase (EGFR TK) inhibitory activity depending on the chirality of the molecule [1]. We have developed...
-
Chapter
HPLC Analysis, Modeling, and Biological Studies of Antiproliferative Heterocyclic Carboxamides
Reversed phase HPLC and MEKC [1] provide excellent possibilities to measure the hydrophobic properties of compounds, characterizing them directly from the chromatographic retention time. The aim in this respec...
-
Chapter
Peptidomimetic tyrosine kinase inhibitors induce non apoptotic, Clarke-III type programmed cell death
-
Article
Open AccessTT-232: An Anti-tumour and Anti-inflammatory Peptide Therapeutic in Clinical Development
TT-232 is a structural derivative of the peptide hormone somatostatin with selective anti-proliferative and anti-inflammatory properties. It has a strong anti-tumour activity both in vitro and in vivo on a wide r...